<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three patients with familial <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> underwent a trial of prophylactic antithrombotic therapy with stanozolol </plain></SENT>
<SENT sid="1" pm="."><plain>An increase in plasma fibrinolytic activity and antithrombin III was seen </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> occurred in two patients; in the first patient <z:mp ids='MP_0005048'>thrombosis</z:mp> was precipitated by venography but in the second no precipitating factor was found </plain></SENT>
<SENT sid="3" pm="."><plain>Our experience suggests that stanozolol is not a suitable prophylactic agent in patients with familial <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> </plain></SENT>
</text></document>